AN2 Therapeutics, Inc. (ANTX) income statement
ANTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.08−0.14 (-2.68%)
Close on Nov 20, 2026Market cap $191.70MP/E –Yield –
AN2 Therapeutics, Inc. financial ratios
See a number that looks wrong?